• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.
    All News #Library
    Quality

    Sagent Pharma: Docetaxel Injection Recall For Particulate Matter

    PR NEWSWIRE

    Pharmaceutics International to manufacture US FDA approved fulvestrant injection

    PHARMABIZ

    Sagent Issues Voluntary Nationwide Recall of Ketorolac Tromethamine Injection

    PR NEWSWIRE

    Sagent Pharma Issues Voluntary Recall of Methylprednisolone Sodium Succinate

    PR NEWSWIRE

    FDA Drug Shortages: Vancomycin Hydrochloride for Injection, USP

    FDA

    FDA Drug Shortages: Piperacillin and Tazobactam (Zosyn) Injection

    FDA

    FDA Drug Shortages: Leucovorin Calcium Lyophilized Powder for Injection

    FDA

    FDA Drug Shortages: Haloperidol Lactate Injection

    FDA

    FDA Drug Shortages: Cefazolin Injection

    FDA

    Sagent Pharmaceuticals Inc, Ongoing Class II recall of Atracurium Besylate Injection, USP, 100 mg per 10 mL (10 mg per mL), Rx Only, 10 mL Multi-Dose Vial, For Intravenous Injection, Mfd. for: Sagent Pharmaceuticals, Schaumberg, IL 60195, NDC 25021-672-10 because of Lack of Assurance of Sterility: Recall initiated due to FDA observations pertaining to aseptic and GMP practices at the manufacturers site potentially impacting product sterility.

    FDA

    Sagent Pharmaceuticals Inc, Ongoing Class II recall of Atracurium Besylate Injection, USP, 50 mg per 5 mL (10 mg per mL), Rx Only, 5 mL Single-Dose Vial, For Intravenous Injection, Mfd. for: Sagent Pharmaceuticals, Schaumberg, IL 60195, NDC 25021-659-05 because of Lack of Assurance of Sterility: Recall initiated due to FDA observations pertaining to aseptic and GMP practices at the manufacturers site potentially impacting product sterility.

    FDA

    Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.